Taking on Harvard
Executive Summary
PhRMA "will fight critics like" Harvard professors (and former New England Journal of Medicine editors) Marcia Angell and Arnold Relman "who would dampen the innovation and creativity of the pharmaceutical industry," association says in letter to the Washington Post. PhRMA sent the letter in response to an editorial by Angell and Relman, "Prescription for Profit," that ran in the Post June 20